Renaissance Technologies’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-547,233
| Closed | -$624K | – | 3950 |
|
|
2024
Q4 | $624K | Sell |
547,233
-90,900
| -14% | -$104K | ﹤0.01% | 2749 |
|
|
2024
Q3 | $651K | Sell |
638,133
-44,601
| -7% | -$45.5K | ﹤0.01% | 2662 |
|
|
2024
Q2 | $556K | Sell |
682,734
-323,025
| -32% | -$263K | ﹤0.01% | 2651 |
|
|
2024
Q1 | $1.26M | Buy |
1,005,759
+506,764
| +102% | +$633K | ﹤0.01% | 2335 |
|
|
2023
Q4 | $444K | Buy |
498,995
+61,467
| +14% | +$54.7K | ﹤0.01% | 2836 |
|
|
2023
Q3 | $398K | Sell |
437,528
-12,205
| -3% | -$11.1K | ﹤0.01% | 2818 |
|
|
2023
Q2 | $425K | Buy |
449,733
+69,500
| +18% | +$65.7K | ﹤0.01% | 2964 |
|
|
2023
Q1 | $364K | Sell |
380,233
-104,500
| -22% | -$100K | ﹤0.01% | 3033 |
|
|
2022
Q4 | $436K | Buy |
484,733
+403,700
| +498% | +$363K | ﹤0.01% | 3025 |
|
|
2022
Q3 | $183K | Sell |
81,033
-6,200
| -7% | -$14K | ﹤0.01% | 3413 |
|
|
2022
Q2 | $220K | Buy |
87,233
+56,700
| +186% | +$143K | ﹤0.01% | 3612 |
|
|
2022
Q1 | $90K | Buy |
30,533
+5,000
| +20% | +$14.7K | ﹤0.01% | 3814 |
|
|
2021
Q4 | $128K | Buy |
+25,533
| New | +$128K | ﹤0.01% | 3637 |
|